Author Question: A client who is suicidal and is withdrawing from controlled substances continues to be agitated and ... (Read 98 times)

mynx

  • Hero Member
  • *****
  • Posts: 555
A client who is suicidal and is withdrawing from controlled substances continues to be agitated and disruptive. When a neuroleptic medication is ordered for agitation, you question its use because you know:
 
  a. the client is a drug abuser and may be reacting this way to get a dose of drugs
  b. all neuroleptics require metabolism through the liver, and drug abusers can't have neuroleptics
  c. chemical restraint is regarded as unethical
  d. the client has a right to die, if he or she so chooses

Question 2

The nurse planning interventions for a client with pain disorder would MOST likely plan interventions that are directed toward:
 
  a. curing the client of all pain to ensure a pain-free life
  b. helping the client control the pain while having a life
  c. teaching the client that pain may control his or her life but not his or her mind
  d. teaching the client how to tolerate pain better



scikid

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

C
Because the client is withdrawing from controlled substances, the use of chemical restraint would be regarded as unethical. The use of chemical restraints could violate the treatment principle of the least restrictive alternative, as well as compromise the client's health as a result of a drug reaction. Other less restrictive options for behavioral control should be explored.

Answer to Question 2

B
The most likely intervention would be helping the client control the pain while having a normal life, because oftentimes chronic pain cannot be completely eliminated medically. In such cases, the pain must be controlled or diminished as best as is possible, while the client develops skills to continue living in spite of the pain.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

For a complete list of videos, visit our video library